Study maps Bifidobacterium genes to guide personalized probiotic development

Probiotics are emerging tools used by neonatal intensive care units to promote healthy outcomes and prevent intestinal diseases such as necrotizing enterocolitis. Approximately one in ten of the youngest preterm infants in the U.S. are treated with probiotics, and studies show that this therapy can reduce all causes of mortality.